These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 32253860

  • 1. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 2. Risk factors for coronary arterial involvement in Turkish children with Kawasaki disease: a multicenter retrospective study.
    Türkuçar S, Kaya ÜA, Çakmak F, Haşlak F, Demir F, Karabulut E, Makay B, Bilginer Y, Ayaz NA, Sözeri B, Kasapçopur Ö, Karagöz T, Ünal N, Özen S, Ünsal E.
    Turk J Pediatr; 2023; 65(1):64-72. PubMed ID: 36866986
    [Abstract] [Full Text] [Related]

  • 3. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 5. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 21; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 6. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 7. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 21; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 8. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M, Andreozzi L, Corinaldesi E, Bodnar T, Lami F, Cicero C, Tchana B, Landini C, Sprocati M, Bigucci B, Balsamo C, Sogno Valin P, Di Fazzio G, Iughetti L, Valletta E, Marchetti F, Donti A, Lanari M.
    Eur J Pediatr; 2019 Mar 21; 178(3):315-322. PubMed ID: 30499051
    [Abstract] [Full Text] [Related]

  • 9. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Mar 21; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 10. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 11. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Sep 27; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 12. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 27; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
    Clin Rheumatol; 2023 Jan 27; 42(1):167-177. PubMed ID: 36129563
    [Abstract] [Full Text] [Related]

  • 14. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 27; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 15. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Sep 27; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 16. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
    Clin Drug Investig; 2011 Sep 27; 31(3):191-9. PubMed ID: 21456105
    [Abstract] [Full Text] [Related]

  • 17. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 27; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 18. Predictors for Intravenous Immunoglobulin Resistance in Patients with Kawasaki Disease.
    Li W, Zhang L, Wang Z, He X, Lin H, Wang Y, Yuan J, Xie X, Zhang X, Qin Y, Huang P.
    Int J Clin Pract; 2022 Nov 27; 2022():2726686. PubMed ID: 35989868
    [Abstract] [Full Text] [Related]

  • 19. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 27; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 20. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 27; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.